Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 482

1.

Multiple risk factors for diabetes mellitus in patients with chronic pancreatitis: A multicentre study of 1117 cases.

Olesen SS, Poulsen JL, Novovic S, Nøjgaard C, Kalaitzakis E, Jensen NM, Engjom T, Tjora E, Waage A, Hauge T, Haas SL, Vujasinovic M, Barauskas G, Pukitis A, Ozola-Zālīte I, Okhlobystin A, Parhiala M, Laukkarinen J, Drewes AM.

United European Gastroenterol J. 2020 Jan 17:2050640620901973. doi: 10.1177/2050640620901973. [Epub ahead of print]

PMID:
32213024
2.

Disrupted functional connectivity of default mode and salience networks in chronic pancreatitis patients.

Muthulingam JA, Hansen TM, Drewes AM, Olesen SS, Frøkjær JB.

Clin Neurophysiol. 2020 Feb 10;131(5):1021-1029. doi: 10.1016/j.clinph.2020.01.016. [Epub ahead of print]

PMID:
32197125
3.

Systematic approach for assessment of imaging features in chronic pancreatitis: a feasibility and validation study from the Scandinavian Baltic Pancreatic Club (SBPC) database.

Lisitskaya MV, Olesen SS, Svarc P, Ebrahim M, Jensen AB, Nøjgaard C, Nørregaard P, Drewes AM, Haldorsen IS, Engjom T, Frøkjær JB.

Abdom Radiol (NY). 2020 Mar 13. doi: 10.1007/s00261-020-02466-x. [Epub ahead of print]

PMID:
32170335
4.

Normative values for gastric motility assessed with the 3D-transit electromagnetic tracking system.

Sutter N, Klinge MW, Mark EB, Nandhra G, Haase AM, Poulsen J, Knudsen K, Borghammer P, Schlageter V, Birch M, Scott SM, Drewes AM, Krogh K.

Neurogastroenterol Motil. 2020 Mar 10:e13829. doi: 10.1111/nmo.13829. [Epub ahead of print]

PMID:
32154975
5.

Progression of parenchymal and ductal findings in patients with chronic pancreatitis: A 4-year follow-up MRI study.

Steinkohl E, Olesen SS, Mark EB, Hansen TM, Frandsen LK, Drewes AM, Frøkjær JB.

Eur J Radiol. 2020 Apr;125:108868. doi: 10.1016/j.ejrad.2020.108868. Epub 2020 Feb 7.

PMID:
32070871
6.

Gastrointestinal pain.

Drewes AM, Olesen AE, Farmer AD, Szigethy E, Rebours V, Olesen SS.

Nat Rev Dis Primers. 2020 Jan 6;6(1):1. doi: 10.1038/s41572-019-0135-7. Review.

PMID:
31907359
7.

Risk of primary brain tumour after breast cancer.

Drewes AM, Møller ME, Hertzum-Larsen R, Engholm G, Storm HH.

Endocr Connect. 2020 Jan;9(1):28-33. doi: 10.1530/EC-19-0498.

8.

A clinically feasible method for the assessment and characterization of pain in patients with chronic pancreatitis.

Phillips AE, Faghih M, Kuhlmann L, Larsen IM, Drewes AM, Singh VK, Yadav D, Olesen SS; Pancreatic Quantitative Sensory Testing (P-QST) Consortium.

Pancreatology. 2020 Jan;20(1):25-34. doi: 10.1016/j.pan.2019.11.007. Epub 2019 Nov 20.

PMID:
31787527
9.

Corrigendum to "Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis" [Pancreatology 18(8) (2018) 847-854].

Dominguez-Munoz JE, Drewes AM, Lindkvist B, Ewald N, Czakó L, Rosendahl J, Löhr JM; HaPanEU/UEG Working Group.

Pancreatology. 2020 Jan;20(1):148. doi: 10.1016/j.pan.2019.10.005. Epub 2019 Nov 19. No abstract available.

PMID:
31757740
10.

Chronic abdominal pain and persistent opioid use after bariatric surgery.

Simoni AH, Ladebo L, Christrup LL, Drewes AM, Johnsen SP, Olesen AE.

Scand J Pain. 2019 Nov 22. pii: /j/sjpain.ahead-of-print/sjpain-2019-0092/sjpain-2019-0092.xml. doi: 10.1515/sjpain-2019-0092. [Epub ahead of print]

PMID:
31756166
11.

Analyzing and Benchmarking Global Consumption Statistics for Opioid Analgesics 2015: Inequality Continues to Increase.

Scholten W, Christensen AE, Olesen AE, Drewes AM.

J Pain Palliat Care Pharmacother. 2020 Mar;34(1):1-12. doi: 10.1080/15360288.2019.1686098. Epub 2019 Nov 22.

PMID:
31755794
12.

Ambulatory assessment of colonic motility using the electromagnetic capsule tracking system: Effect of opioids.

Mark EB, Klinge MW, Grønlund D, Poulsen JL, Schlageter V, Scott SM, Krogh K, Drewes AM.

Neurogastroenterol Motil. 2020 Mar;32(3):e13753. doi: 10.1111/nmo.13753. Epub 2019 Nov 12.

PMID:
31721398
13.

A Clinical Feasible Method for Computed Tomography-Based Assessment of Sarcopenia in Patients With Chronic Pancreatitis.

Ozola-Zālīte I, Frøkjær JB, Mark EB, Gudauskas T, Gudauskas L, Dedelaite M, Bieliuniene E, Ignatavicius P, Pukitis A, Drewes AM, Olesen SS.

Pancreas. 2019 Nov/Dec;48(10):1354-1359. doi: 10.1097/MPA.0000000000001439.

PMID:
31688601
14.

Symptoms of mast cell activation syndrome in functional gastrointestinal disorders.

Wilder-Smith CH, Drewes AM, Materna A, Olesen SS.

Scand J Gastroenterol. 2019 Nov;54(11):1322-1325. doi: 10.1080/00365521.2019.1686059. Epub 2019 Nov 5.

PMID:
31687861
15.

Effects of Vortioxetine and Escitalopram on Electroencephalographic Recordings - A Randomized, Crossover Trial in Healthy Males.

Nissen TD, Laursen B, Viardot G, l'Hostis P, Danjou P, Sluth LB, Gram M, Bastlund JF, Christensen SR, Drewes AM.

Neuroscience. 2020 Jan 1;424:172-181. doi: 10.1016/j.neuroscience.2019.09.039. Epub 2019 Oct 31.

PMID:
31678343
16.

Correction: Predictors of opioid efficacy in patients with chronic pain: A prospective multicenter observational cohort study.

Grosen K, Olesen AE, Gram M, Jonsson T, Kamp-Jensen M, Andresen T, Nielsen C, Pozlep G, Pfeiffer-Jensen M, Morlion B, Drewes AM.

PLoS One. 2019 Oct 30;14(10):e0224779. doi: 10.1371/journal.pone.0224779. eCollection 2019.

17.

The Incidence of Sexual Dysfunction in Patients With Irritable Bowel Syndrome.

Sørensen J, Schantz Laursen B, Drewes AM, Krarup AL.

Sex Med. 2019 Dec;7(4):371-383. doi: 10.1016/j.esxm.2019.08.010. Epub 2019 Oct 8. Review.

18.

Study protocol for a randomised double-blinded, sham-controlled, prospective, cross-over clinical trial of vagal neuromodulation for pain treatment in patients with chronic pancreatitis.

Muthulingam JA, Olesen SS, Hansen TM, Brock C, Drewes AM, Frøkjær JB.

BMJ Open. 2019 Aug 23;9(7):e029546. doi: 10.1136/bmjopen-2019-029546.

19.

Population pharmacokinetic-pharmacodynamic modelling of liquid and controlled-release formulations of oxycodone in healthy volunteers.

Ladebo L, Foster DJR, Abuhelwa AY, Upton RN, Kongstad KT, Drewes AM, Christrup LL, Olesen AE.

Basic Clin Pharmacol Toxicol. 2020 Mar;126(3):263-276. doi: 10.1111/bcpt.13330. Epub 2019 Oct 28.

PMID:
31597014
20.

Effects of Naloxegol on Gastrointestinal Transit and Colonic Fecal Volume in Healthy Participants Receiving Oxycodone.

Olesen AE, Grønlund D, Mark EB, Krogh K, Frøkjær JB, Drewes AM.

J Neurogastroenterol Motil. 2019 Oct 30;25(4):602-610. doi: 10.5056/jnm18079.

21.

Normative values for region-specific colonic and gastrointestinal transit times in 111 healthy volunteers using the 3D-Transit electromagnet tracking system: Influence of age, gender, and body mass index.

Nandhra GK, Mark EB, Di Tanna GL, Haase AM, Poulsen J, Christodoulides S, Kung V, Klinge MW, Knudsen K, Borghammer P, Andersen KO, Fynne L, Sutter N, Schlageter V, Krogh K, Drewes AM, Birch M, Scott SM.

Neurogastroenterol Motil. 2020 Feb;32(2):e13734. doi: 10.1111/nmo.13734. Epub 2019 Sep 29.

PMID:
31565841
22.

Cingulate glutamate levels associate with pain in chronic pancreatitis patients.

Hansen TM, Muthulingam JA, Drewes AM, Olesen SS, Frøkjær JB.

Neuroimage Clin. 2019;23:101925. doi: 10.1016/j.nicl.2019.101925. Epub 2019 Jul 2.

23.

Pancreatic calcifications associate with diverse aetiological risk factors in patients with chronic pancreatitis: A multicentre study of 1500 cases.

Olesen SS, Lisitskaya MV, Drewes AM, Novovic S, Nøjgaard C, Kalaitzakis E, Jensen NM, Engjom T, Erchinger F, Waage A, Hauge T, Haas SL, Vujasinovic M, Lindkvist B, Zviniene K, Pukitis A, Ozola-Zālīte I, Okhlobystin A, Parhiala M, Laukkarinen J, Frøkjær JB; Scandinavian Baltic Pancreatic Club.

Pancreatology. 2019 Oct;19(7):922-928. doi: 10.1016/j.pan.2019.08.009. Epub 2019 Aug 21.

PMID:
31462382
24.

Characterisation of the fibroinflammatory process involved in progression from acute to chronic pancreatitis: study protocol for a multicentre, prospective cohort study.

Novovic S, Borch A, Werge M, Karran D, Gluud L, Schmidt PN, Hansen EF, Nøjgaard C, Jensen AB, Jensen FK, Frøkjær JB, Hansen MB, Jørgensen LN, Drewes AM, Olesen SS.

BMJ Open. 2019 Aug 21;9(8):e028999. doi: 10.1136/bmjopen-2019-028999.

25.

Pancreas-specific plasma amylase for assessment and diagnosis of chronic pancreatitis: New insights on an old topic.

Olesen SS, Krarup H, Poulsen JL, Christensen JH, Sheel ARG, Sutton R, Greenhalf W, Halloran C, Drewes AM.

United European Gastroenterol J. 2019 Aug;7(7):955-964. doi: 10.1177/2050640619846011. Epub 2019 Apr 16.

26.

Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics.

Søfteland E, Poulsen JL, Starup-Linde J, Christensen TT, Olesen SS, Singh S, Vestergaard P, Drewes AM, Dimcevski G.

Eur J Intern Med. 2019 Oct;68:18-22. doi: 10.1016/j.ejim.2019.07.021. Epub 2019 Aug 8.

PMID:
31402275
27.

Liraglutide treatment reduced interleukin-6 in adults with type 1 diabetes but did not improve established autonomic or polyneuropathy.

Brock C, Hansen CS, Karmisholt J, Møller HJ, Juhl A, Farmer AD, Drewes AM, Riahi S, Lervang HH, Jakobsen PE, Brock B.

Br J Clin Pharmacol. 2019 Nov;85(11):2512-2523. doi: 10.1111/bcp.14063. Epub 2019 Aug 30.

28.

Association of multiple patient and disease characteristics with the presence and type of pain in chronic pancreatitis.

Olesen SS, Kuhlmann L, Novovic S, Nøjgaard C, Kalaitzakis E, Jensen NM, Engjom T, Dimcevski G, Waage A, Haas SL, Vujasinovic M, Riauka R, Pukitis A, Ozola-Zālīte I, Okhlobystin A, Parhiala M, Laukkarinen J, Drewes AM; Scandinavian Baltic Pancreatic Club.

J Gastroenterol Hepatol. 2020 Feb;35(2):326-333. doi: 10.1111/jgh.14783. Epub 2019 Jul 31.

PMID:
31314128
29.

Patient and Disease Characteristics Associate With Sensory Testing Results in Chronic Pancreatitis.

Kuhlmann L, Olesen SS, Grønlund D, Olesen AE, Phillips AE, Faghih M, Drewes AM.

Clin J Pain. 2019 Sep;35(9):786-793. doi: 10.1097/AJP.0000000000000740.

30.

Pathophysiology and management of diabetic gastroenteropathy.

Meldgaard T, Keller J, Olesen AE, Olesen SS, Krogh K, Borre M, Farmer A, Brock B, Brock C, Drewes AM.

Therap Adv Gastroenterol. 2019 Jun 17;12:1756284819852047. doi: 10.1177/1756284819852047. eCollection 2019. Review.

31.

Complications to Chronic Pancreatitis and Etiological Risk Factors: A Continental Divide?

Olesen SS, Drewes AM.

Am J Gastroenterol. 2019 Aug;114(8):1353. doi: 10.14309/ajg.0000000000000302. No abstract available.

PMID:
31211705
32.

The Effects of Filter's Class, Cutoff Frequencies, and Independent Component Analysis on the Amplitude of Somatosensory Evoked Potentials Recorded from Healthy Volunteers.

Navid MS, Niazi IK, Lelic D, Drewes AM, Haavik H.

Sensors (Basel). 2019 Jun 8;19(11). pii: E2610. doi: 10.3390/s19112610.

33.

Altered brain morphology in chronic pancreatitis patients and its association with pain and other disease characteristics.

Muthulingam JA, Hansen TM, Olesen SS, Drewes AM, Frøkjær JB.

Eur J Gastroenterol Hepatol. 2019 Sep;31(9):1092-1098. doi: 10.1097/MEG.0000000000001470.

PMID:
31180988
34.

Controversies on the endoscopic and surgical management of pain in patients with chronic pancreatitis: pros and cons!

Drewes AM, Kempeneers MA, Andersen DK, Arendt-Nielsen L, Besselink MG, Boermeester MA, Bouwense S, Bruno M, Freeman M, Gress TM, van Hooft JE, Morlion B, Olesen SS, van Santvoort H, Singh V, Windsor J.

Gut. 2019 Aug;68(8):1343-1351. doi: 10.1136/gutjnl-2019-318742. Epub 2019 May 25. No abstract available.

35.

Premedication with corticosteroids does not impact the pharmacokinetics of infliximab in inflammatory bowel disease irrespective of azathioprine cotreatment.

Larsen L, Jess T, Drewes AM, Dige A, Fallingborg J, Jacobsen BA, Aagaard B, Agnholt J.

Eur J Gastroenterol Hepatol. 2019 Aug;31(8):964-967. doi: 10.1097/MEG.0000000000001440.

PMID:
31094854
36.

The effects of chiropractic spinal manipulation on central processing of tonic pain - a pilot study using standardized low-resolution brain electromagnetic tomography (sLORETA).

Navid MS, Lelic D, Niazi IK, Holt K, Mark EB, Drewes AM, Haavik H.

Sci Rep. 2019 May 6;9(1):6925. doi: 10.1038/s41598-019-42984-3.

37.

The sentinel acute pancreatitis event hypothesis revisited.

Olesen SS, Drewes AM, Novovic S, Nøjgaard C.

Pancreatology. 2019 Jun;19(4):614-615. doi: 10.1016/j.pan.2019.03.007. Epub 2019 Apr 3. No abstract available.

PMID:
30962131
38.

Reply.

Wilder-Smith CH, Olesen SS, Materna A, Drewes AM.

Gastroenterology. 2019 Mar;156(4):1221-1222. doi: 10.1053/j.gastro.2019.02.025. Epub 2019 Feb 18. No abstract available.

PMID:
30790553
39.

Pathophysiology and management of opioid-induced constipation: European expert consensus statement.

Farmer AD, Drewes AM, Chiarioni G, De Giorgio R, O'Brien T, Morlion B, Tack J.

United European Gastroenterol J. 2019 Feb;7(1):7-20. doi: 10.1177/2050640618818305. Epub 2018 Dec 14. Review. Erratum in: United European Gastroenterol J. 2019 Mar;7(2):178.

40.

Quantities of comorbidities affects physical, but not mental health related quality of life in type 1 diabetes with confirmed polyneuropathy.

Wegeberg AL, Meldgaard T, Hyldahl S, Jakobsen PE, Drewes AM, Brock B, Brock C.

World J Diabetes. 2019 Feb 15;10(2):87-95. doi: 10.4239/wjd.v10.i2.87.

41.

Chronic Pancreatitis Is Characterized by Distinct Complication Clusters That Associate With Etiological Risk Factors.

Olesen SS, Nøjgaard C, Poulsen JL, Haas SL, Vujasinovic M, Löhr M, Lindkvist B, Bexander L, Gulbinas A, Kalaitzakis E, Ebrahim M, Erchinger F, Engjom T, Roug S, Novovic S, Hauge T, Waage A, Laukkarinen J, Parhiala M, Pukitis A, Ozola-Zālīte I, Drewes AM; Scandinavian Baltic Pancreatic Club.

Am J Gastroenterol. 2019 Apr;114(4):656-664. doi: 10.14309/ajg.0000000000000147.

PMID:
30741740
42.

Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes.

Hansen TM, Brock B, Juhl A, Drewes AM, Vorum H, Andersen CU, Jakobsen PE, Karmisholt J, Frøkjær JB, Brock C.

J Diabetes Complications. 2019 Apr;33(4):323-328. doi: 10.1016/j.jdiacomp.2018.12.016. Epub 2019 Jan 4.

PMID:
30733057
43.

Sarcopenia associates with increased hospitalization rates and reduced survival in patients with chronic pancreatitis.

Olesen SS, Büyükuslu A, Køhler M, Rasmussen HH, Drewes AM.

Pancreatology. 2019 Mar;19(2):245-251. doi: 10.1016/j.pan.2019.01.006. Epub 2019 Jan 14.

PMID:
30665702
44.

Mechanism-based pain management in chronic pancreatitis - is it time for a paradigm shift?

Kuhlmann L, Olesen SS, Olesen AE, Arendt-Nielsen L, Drewes AM.

Expert Rev Clin Pharmacol. 2019 Mar;12(3):249-258. doi: 10.1080/17512433.2019.1571409. Epub 2019 Feb 5. Review.

PMID:
30664364
45.

MRI analysis of fecal volume and dryness: Validation study using an experimental oxycodone-induced constipation model.

Mark EB, Bødker MB, Grønlund D, Østergaard LR, Frøkjaer JB, Drewes AM.

J Magn Reson Imaging. 2019 Sep;50(3):733-745. doi: 10.1002/jmri.26628. Epub 2019 Jan 4.

PMID:
30609164
46.

Cortical networks are disturbed in people with cirrhosis even in the absence of neuropsychometric impairment.

Olesen SS, Jackson CD, Gram M, Zacharias HD, Dirks M, Weissenborn K, Drewes AM, Morgan MY.

Clin Neurophysiol. 2019 Mar;130(3):419-427. doi: 10.1016/j.clinph.2018.11.011. Epub 2018 Nov 26.

PMID:
30552046
47.

[Acromegaly].

Arlien-Søborg MC, Drewes AM, Pfeiffer-Jensen M, Jørgensen JOL.

Ugeskr Laeger. 2018 Dec 3;180(49). pii: V09170637. Danish.

PMID:
30520722
48.

Quantifying the Adequacy of Opioid Analgesic Consumption Globally: An Updated Method and Early Findings.

Scholten WK, Christensen AE, Olesen AE, Drewes AM.

Am J Public Health. 2019 Jan;109(1):52-57. doi: 10.2105/AJPH.2018.304753. Epub 2018 Nov 29.

49.

A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication.

Olesen AE, Broens S, Olesen SS, Niesters M, van Velzen M, Drewes AM, Dahan A, Olofsen E.

J Pharmacol Exp Ther. 2019 Nov;371(2):416-421. doi: 10.1124/jpet.118.253716. Epub 2018 Nov 15.

PMID:
30442653
50.

[Acromegaly and symptoms of the motor apparatus].

Drewes AM, Arlien-Søborg MC, Lunde Jørgensen JO, Jensen MP.

Ugeskr Laeger. 2018 Nov 12;180(46). pii: V05170435. Danish.

PMID:
30417820

Supplemental Content

Loading ...
Support Center